• HealthTech 250
  • Our Solutions
    • HealthTech Alpha
    • Innovation Playbook
      • Digital Health Landscape Readiness Assessment
      • Competitive Benchmarking
      • Digital Health Portfolio Review
      • Next Gen Scouting
  • Our Work
  • Who We Help
    • Lifesciences
    • Insurance
    • Investors
  • Research
  • Events
  • About Us
SUBSCRIBE
  • HealthTech 250
  • Our Solutions
    • HealthTech Alpha
    • Innovation Playbook
      • Digital Health Landscape Readiness Assessment
      • Competitive Benchmarking
      • Digital Health Portfolio Review
      • Next Gen Scouting
  • Our Work
  • Who We Help
    • Lifesciences
    • Insurance
    • Investors
  • Research
  • Events
  • About Us
SUBSCRIBE

Macro and micro-environment analysis in RWD & RWE

Assessment of the macro and micro-environment for Real World Data and Real Word Evidence for a Pharma CVC

Vertical :
  • Investors
  • Geography : Key Asia Pacific market

    Solution:

    • Digital Health Landscape Readiness Assessment
    • Next Gen Scouting

    Objective

    The Corporate Venture Capital (CVC) arm of a global pharmaceutical company wanted to analyse a specific key APAC market to assess both the macro and micro-environment for Real World Data and Real Word Evidence to inform corporate strategy and prioritise key ventures for further engagement. By utilising Galen Growth's proven PlayBook methodology, we enabled our client to fully understand the RWD and RWE innovation environment and readiness to enable the identification and prioritisation of Digital Health ventures with the right capabilities and achievements. Further prioritisation driven by Deep Dive analysis of select ventures, to map their operating model, leading to direct engagement with their leadership team. The examination covered 1 key therapeutic area in 1 key APAC country. We screened 15 ventures and, in collaboration with our client, shortlisted 7.

    Outcomes

    The data, intel and insights from this comprehensive analysis allowed our investor client to better understand the digital health landscape of this key APAC market, identify “ready-made” RWE integrated solutions and develop appropriate scenarios / options for potential “integrated solutions” models where these are potentially complimentary.

    Key Results

    Number of countries 1
    Number of therapeutic areas 1
    Number of ventures screened 15
    Number of ventures shortlisted 7

    Take The Next Step

    Contact us to explore how your organisation can fast track its Digital Health strategy with Galen Growth

    Subscribe to our ecosystem news

    Sign up to join the only global HealthTech community.

    Subscribe

    HealthTech Alpha
    Privacy policy
    Terms

    About us
    Contact us
    Privacy policy
    Terms

    Innovation Playbook
    Healthtech alpha
    Events
    Research

    Galen Growth Asia Singapore

    Galen Growth Europe Switzerland

    Galen Growth N. America USA

    © Galen Growth 2023

    Overview

    Category

    Stage

    Total Funding

    GGA Score

    powered by
    See Full Startup Profile